This FAQ breaks down the AAP's newest COVID-19, RSV, and influenza recommendations for clinicians who want a quick refresher on what changed for the 2026-2027 season.
|Articles|September 4, 2014
The H1N1 flu virus and vaccination (VIDEO)
Watch to learn about the flu season and it's impact on younger adults with the H1N1 strain of the flu virus and how important the flu vaccine is for this part of the population.
Advertisement
Watch to learn about the flu season and it's impact on younger adults with the H1N1 strain of the flu virus and how important the flu vaccine is for this part of the population.
This video is part of the
Advertisement
Related to this article
Five rapid developments — new mRNA flu vaccine, CDC director, ACIP/NVAC charters, a vaccine order, and an HHS RFI — roil the 2026 schedule.
Court fight over CDC 2026 childhood vaccine schedule shifts shots to shared decision-making; experts warn lower uptake for Hep A, B, flu, COVID.
New evidence supports influenza, COVID-19, and RSV immunizations for reducing severe respiratory illness and hospitalization.
CDC's 2025 NIS-Teen data show HPV vaccine coverage flat for a fourth year, with rural adolescents 12 points behind urban peers in receiving ≥1 dose.
The AAP's 2026-2027 policy recommends universal vaccination for infants 6-23 months and a risk-based single dose for children 2-18 years.
AAP guidance expands RSV immunization eligibility for children aged 8 through 19 months at high risk of severe disease.
Lori Handy, MD, says vaccine conversations with hesitant families should prioritize trust, follow-up, and the benefits for the individual child.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Updated AAP guidance changes iron deficiency screening and treatment in children
2
FDA approves levacetylleucine as first treatment for ataxia in ataxia-telangiectasia
3
FDA grants priority review to efzimfotase alfa for hypophosphatasia in patients aged 2 years and older
4
Formula Feeding and the Gut Microbiome: Closing the Gap
5